In conclusion, we provide quantitative evidence for differences between two variants of the C26 murine colon carcinoma in terms of in vivo 5-FU uptake and anabolic conversion as well as recovery from treatment via clearance of 5-FU from RNA and induction of TS. This evidence concerns the gene TYMS and colon carcinoma.